As of April 30, there were 684 cases of Candida auris, a deadly emerging fungus, in the U.S., according to the CDC.
There were 654 confirmed and 30 probable cases at the end of April. The case count jumped by 71 in the span of one month from March 31, when there were 613 cases reported by the CDC.
Illinois, New Jersey and New York are still reporting the highest number of cases, with New York leading the pack with 334 confirmed and four probable cases.
C. auris, a type of yeast, is often multidrug-resistant and causes bloodstream infections, wound infections and ear infections. People receiving treatment via lines and tubes that go into their body, such as breathing and feeding tubes, seem to be at highest risk for C. auris infection.
C. auris cases have been reported globally, including multiple cases in Australia, Canada, China, Colombia, France, Germany and India.